The HLA crossroad in tumor immunology

This publication has 33 references indexed in Scilit:

• HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story
  Molecular Medicine Today, 1999
• The host—tumor immune conflict: from immunosuppression to resistance and destruction
  Immunology Today, 1997
• Natural history of HLA expression during tumour development
  Immunology Today, 1993
• Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia.
  Proceedings of the National Academy of Sciences, 1989
• The biological consequences of altered MHC expression on tumours
  British Medical Bulletin, 1987
• The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides
  Cell, 1986
• Antigenic Tumor Cell Variants Obtained with Mutagens
  Advances in Cancer Research, 1983
• Variation in MHC Antigenic Profiles of Tumor Cells and its Biological Effects
  Immunological Reviews, 1981
• ABSENCE OF FOUR H‐2^d ANTIGENIC SPECIFICITIES IN AN H‐2^d SARCOMA
  International Journal of Immunogenetics, 1979
• Further evidence for derepression of H–2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines
  Nature, 1976